Stockholders’ Equity (Details) - Schedule of Restricted Common Stock	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Resricted Common Stock [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Common Stock [Line Items]
Number of shares, Non-vested, Beginning balance
Weighted average grant date fair value, Non–vested, Beginning balance (in Dollars per share) | $ / shares
Number of shares, Granted	15,318
Weighted average grant date fair value, Granted (in Dollars per share) | $ / shares	$ 9.15
Number of shares, Vested	(15,318)
Weighted average grant date fair value, Vested (in Dollars per share) | $ / shares	$ 9.15
Number of shares, Non-vested, Ending balance
RSUs [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Common Stock [Line Items]
Number of shares, Non-vested, Beginning balance	134,799
Weighted average grant date fair value, Non–vested, Beginning balance (in Dollars per share) | $ / shares	$ 28.74
Number of shares, Granted	112,033
Weighted average grant date fair value, Granted (in Dollars per share) | $ / shares	$ 14.02
Number of shares, Vested	(74,786)
Weighted average grant date fair value, Vested (in Dollars per share) | $ / shares	$ 29.93
Number of shares, Forfeited	(11,411)
Weighted average grant date fair value, Forfeited (in Dollars per share) | $ / shares	$ 13.65
Number of shares, Non-vested, Ending balance	160,635
Weighted average grant date fair value, Non–vested, Ending balance (in Dollars per share) | $ / shares	$ 18.99
PSUs [Member]
Stockholders’ Equity (Details) - Schedule of Restricted Common Stock [Line Items]
Number of shares, Non-vested, Beginning balance
Number of shares, Granted	88,965
Weighted average grant date fair value, Granted (in Dollars per share) | $ / shares	$ 9.62
Number of shares, Vested
Number of shares, Forfeited
Number of shares, Non-vested, Ending balance	88,965
Weighted average grant date fair value, Non–vested, Ending balance (in Dollars per share) | $ / shares	$ 9.62